Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
SURF-200
- Development stage
- Unknown
- Lead developer
- Surface Ophthalmics
- Modality
- Small Molecules
- Administration
- Ophthalmic
01
Overview
**SURF-200** is an investigational ophthalmic drug being developed for the treatment of acute (episodic) dry eye disease. It consists of low-concentration betamethasone, a potent corticosteroid, formulated in the Klarity vehicle—an excipient designed to enhance ocular surface protection and tolerability. Betamethasone is well established globally as a corticosteroid but is being introduced into ocular therapy in the U.S. through this product. The formulation is intended to provide efficacy comparable to currently available ocular steroids with potentially improved safety and tolerability. SURF-200 is in Phase II clinical development, with trials focused on symptom improvement in acute dry eye patients[1][4][5][6].
- Brand names
- SURF-200SURF200SURF 200
- Other names
- SURF-200SURF200SURF 200
02
Targets
GR (Glucocorticoid receptor)
Beyond the preview
Go deeper on SURF-200.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on SURF-200.